Details
Product Name in the RMS: Atosiban 37.5 mg/5 ml concentrate for solution for infusion
MR Number: NL/H/4551/001
Date of outcome: 22.07.2015
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Initial Application Generic Chemical Substance Prescription Only |
Active Substances |
atosiban acetate 37,5 mg/ml |
Form | Concentrate for solution for infusion |
MA Holder in the RMS |
Accord Healthcare Limited. Sage House, 319 Pinner road, North Harrow, Middlesex, HA1 4HF UK |
RMS | Netherlands |
Date of last change | 08.06.2020 |
ATC-Code |
G02CX01 Atosiban |
CMS Country | Domestic Product Name |
---|---|
Austria | Atosiban Accord 37,5 mg/5 ml Konzentrat zur Herstellung einer Infusionslösung |
Czech Republic | Atosiban Accord 37.5 mg/5 ml koncentrát pro infuzní roztok |
Denmark | |
Finland | |
France | |
Germany | Atosiban Accord 37,5 mg/5ml |
Ireland | |
Italy | |
Lithuania | Atosiban Accord 37,5 mg/5 ml koncentratas infuziniam tirpalui |
Malta | Atosiban Concentrate for Soln for Inf 37.5mg/5ml |
Norway | Atosiban Accord |
Poland | Atosiban Accord |
Portugal | |
Spain | |
Sweden | Atosiban Accord |
United Kingdom | Atosiban 37.5 mg/5 ml concentrate for solution for infusion |
Documents | |
---|---|
FinalPL: | NL_H_4551_001_FinalPL_1of2.pdf (17.01.2020) |
FinalPL: | NL_H_4551_001_FinalPL_2of2.pdf (17.01.2020) |